We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IVF:NASDAQINVO Fertility, Inc. analysis

Data as of Sep 1, 2026 - not real-time

Latest price
$1.03
Risk: high
9/10High risk

Summary

At $1.03, INVO Fertility, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. With RSI at 45.9 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $0.9540 and resistance at $2.80.
Multiples put this in undervalued territory: 0.0 times earnings against the sector's 30.4. Consensus targets land 1841.7% above where the shares trade now. Revenue is growing at 16.7% on a -70.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 160.9%, a beta of -2.28 and a maximum drawdown of 98.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top market events

  • INVO Fertility NASDAQ:IVF reported a 17% increase in second-quarter 2026 revenue to $2.
  • INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth And Clinic Platform Profitability.
  • Q2 2026 revenue increased 17% as INVO advances organic growth and a disciplined acquisition strategy focused on...

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.89
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 0.0 versus sector average of 30.4
  • Trading below the 200-day average of 3.89

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 0.0 versus sector average of 30.4
  • Negative profit margin of -70.2%
  • Analyst targets imply +1841.7% versus the current price

Key metrics

Financial health

Revenue Growth16.70%
Profit Margin-70.18%
P/E Ratio0.0
ROE-55.28%
ROA-16.41%
Debt/Equity23.78
P/B Ratio0.1
Op. Cash Flow$-4769352
Free Cash Flow$-4820978
Industry P/E30.4

Technical analysis

TrendBearish
RSI45.9
Support$0.95
Resistance$2.80
MA 20$1.09
MA 50$1.19
MA 200$3.89
MACDBearish
VolumeDecreasing
Fear & Greed Index93.61

Valuation

Target Price$20.00
Upside/Downside1841.75%
GradeUndervalued
TypeBlend

Risk assessment

Beta-2.28
Volatility160.95%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.